Read + Share
Batalini F, Xiong N, Tayob N, Polak M, et al. Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced
Triple-Negative Breast Cancer. Clin Cancer Res 2022 Feb 11. pii: 1078-0432.CCR-21-3045.
PMID: 35149538
|
 |
|
Batalini F, Xiong N, Tayob N, Polak M, et al. Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced
Triple-Negative Breast Cancer. Clin Cancer Res 2022 Feb 11. pii: 1078-0432.CCR-21-3045.
PMID: 35149538
|
|
|
|